| Biotechnology Industry | Healthcare Sector | Mr. Tingchun Wang M.D., Ph.D. CEO | XSHE Exchange | CNE100001Y00 ISIN |
| CN Country | 1,205 Employees | 17 Jun 2026 Last Dividend | 20 Oct 2015 Last Split | - IPO Date |
Boji Medical Technology Co., Ltd., initially known as Guangzhou Boji Medical & Biotechnological Co., Ltd., is a reputable entity that specializes in offering professional contract research services tailored for the pharmaceutical sector, both within China and on an international level. Founded in 1998 and having its headquarters situated in Guangzhou, China, the company has established itself as a key player in the research, development, and production of drugs and medical devices. In September 2021, it underwent a strategic rebranding, adopting its current name to reflect its broadened scope and commitment to innovation in medical technology. Boji Medical Technology plays a pivotal role in advancing pharmaceutical research by providing a comprehensive range of services from pre-clinical trials to clinical research and beyond.
Boji Medical Technology offers extensive services in pre-clinical research, ensuring that new drugs and medical devices are scrutinized under laboratory conditions to establish their safety and efficacy before they proceed to clinical trials. This foundational step is crucial for identifying potential therapeutic benefits and minimizing risks.
Once pre-clinical testing is satisfactorily completed, Boji assists in the advancement of drugs and devices through clinical research. This phase involves testing on human subjects to gather critical data on effectiveness, side effects, and the optimal dosing regimen. Boji's expertise ensures these trials are conducted with the utmost precision and regulatory compliance.
The company also specializes in the production of clinical-grade drugs, adhering to stringent manufacturing practices. This includes the production of small batches for use in clinical trials, ensuring that every stage of drug development is meticulously overseen for quality and safety.
Boji offers testing services for medical products alongside pilot test scale-ups, which are essential for transitioning from lab-scale production to larger batches. This process involves refinement of the production process to ensure it is scalable and economically viable for commercial production.
In alignment with regulatory requirements, the company provides services for process verification through batch production. This critical step verifies that the manufacturing process is reproducible and produces a consistent product batch after batch.
Boji facilitates the drug registration and approval process, leveraging its expertise to navigate the complex regulatory landscape. This service ensures that drugs and medical devices comply with all regulatory standards necessary for market entry.
Beyond traditional research and development services, Boji engages in the screening, evaluation, verification, and trading of technological achievements acquired during the new drug development process. This aspect of their business focuses on maximizing the value of innovative discoveries and ensuring they reach their full potential in the marketplace.